Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

October 26, 2011

Primary Completion Date

December 5, 2012

Study Completion Date

December 5, 2012

Conditions

Osteoporosis

Interventions

DRUG

MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet

One combination tablet orally once a week

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT01437111 - Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329) | Biotech Hunter | Biotech Hunter